Your browser doesn't support javascript.
loading
Cancer cell-derived type I interferons instruct tumor monocyte polarization.
Kwart, Dylan; He, Jing; Srivatsan, Subhashini; Lett, Clarissa; Golubov, Jacquelynn; Oswald, Erin M; Poon, Patrick; Ye, Xuan; Waite, Janelle; Zaretsky, Arielle Glatman; Haxhinasto, Sokol; Au-Yeung, Elsa; Gupta, Namita T; Chiu, Joyce; Adler, Christina; Cherravuru, Samvitha; Malahias, Evangelia; Negron, Nicole; Lanza, Kathryn; Coppola, Angel; Ni, Min; Song, Hang; Wei, Yi; Atwal, Gurinder S; Macdonald, Lynn; Oristian, Nicole Stokes; Poueymirou, William; Jankovic, Vladimir; Fury, Matthew; Lowy, Israel; Murphy, Andrew J; Sleeman, Matthew A; Wang, Bei; Skokos, Dimitris.
Afiliación
  • Kwart D; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • He J; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Srivatsan S; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Lett C; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Golubov J; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Oswald EM; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Poon P; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Ye X; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Waite J; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Zaretsky AG; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Haxhinasto S; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Au-Yeung E; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Gupta NT; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Chiu J; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Adler C; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Cherravuru S; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Malahias E; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Negron N; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Lanza K; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Coppola A; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Ni M; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Song H; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Wei Y; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Atwal GS; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Macdonald L; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Oristian NS; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Poueymirou W; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Jankovic V; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Fury M; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Lowy I; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Murphy AJ; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Sleeman MA; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA.
  • Wang B; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA. Electronic address: bei.wang@regeneron.com.
  • Skokos D; Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA. Electronic address: dimitris.skokos@regeneron.com.
Cell Rep ; 41(10): 111769, 2022 12 06.
Article en En | MEDLINE | ID: mdl-36476866
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón Tipo I / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cell Rep Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interferón Tipo I / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cell Rep Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos